US Stock MarketDetailed Quotes
CATX Perspective Therapeutics
- 12.6400
- +0.7500+6.31%
Close Jul 19 16:00 ET
- 12.7600
- +0.1200+0.95%
Post 18:22 ET
852.32MMarket Cap-6723P/E (TTM)
12.8700High11.8650Low758.23KVolume12.0000Open11.8900Pre Close9.43MTurnover1.72%Turnover RatioLossP/E (Static)67.43MShares19.050052wk High3.71P/B557.77MFloat Cap2.050052wk Low--Dividend TTM44.13MShs Float85.0000Historical High--Div YieldTTM8.45%Amplitude0.0300Historical Low12.4330Avg Price1Lot Size
About Perspective Therapeutics Company
Perspective Therapeutics, Inc. is a medical technology and radiopharmaceutical company, which engages in the provision of treatment applications for cancers. The company was founded in 1983 and is headquartered in Seattle, WA.
Company Profile
SymbolCATX
Company NamePerspective Therapeutics
Listing DateApr 19, 2007
Founded1983
CEOMr. Johan M. (Thijs) Spoor
MarketAMEX
Employees119
Securities TypeOrdinary Shares
Fiscal Year Ends12-31
Address2401 Elliott Avenue,Suite 320
CitySeattle
ProvinceWashington
CountryUnited States of America
Zip Code98121
Phone1-206-676-0900
Company Executives
- Name
- Position
- Salary
- Johan M. (Thijs) Spoor
- Director and Chief Executive Officer
- 1.46M
- Jonathan R. Hunt
- Chief Financial Officer and Co-Principal Financial Officer
- 1.17M
- Dr. Markus Puhlmann, M.D.,PhD
- Chief Medical Officer
- 900.09K
- Mark Austin
- Vice President, Finance, Corporate Controller, Co-Principal Financial and Principal Accounting Officer and Corporate Secretary
- --
- Lori A. Woods
- Chairman of the Board
- 671.73K
- Robert Froman Willian, III
- Independent Director
- 320.06K
- Heidi Henson, C.P.A.
- Independent Director
- 390.70K
- Dr. Frank Morich, M.D.,PhD
- Independent Director
- 320.06K
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg